PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20609063-12	2010	CONCLUSIONS: The obtained results suggest that the preferential cyclooxygenase-2 inhibitor etoricoxib significantly reduced the anticonvulsant action of phenytoin and significantly increased the beneficial action of diazepam against maximal electroshock and pentylenetetrazole-induced convulsions in a mouse model.	Etoricoxib	91-101	prostaglandin-endoperoxide synthase 2	Mus musculus	64-80	
21441618-0	2011	Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor.	Etoricoxib	101-111	prostaglandin-endoperoxide synthase 2	Mus musculus	125-130	
32330796-1	2020	Etoricoxib, a selective Cyclooxygenase-2 (COX-2) inhibitor, is commonly used in osteoarthritis (OA) for pain relief, however, little is known about the effects on subchondral bone.	Etoricoxib	0-10	prostaglandin-endoperoxide synthase 2	Mus musculus	24-40	
32330796-1	2020	Etoricoxib, a selective Cyclooxygenase-2 (COX-2) inhibitor, is commonly used in osteoarthritis (OA) for pain relief, however, little is known about the effects on subchondral bone.	Etoricoxib	0-10	prostaglandin-endoperoxide synthase 2	Mus musculus	42-47